Skip to main content

FGL vs Palmitoyl Tripeptide-1

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

FGL

FGL (FG Loop) is a synthetic peptide that mimics the neural cell adhesion molecule (NCAM) FG loop region. It promotes neuroplasticity and has shown cognitive-enhancing effects in research.

Full details →

Palmitoyl Tripeptide-1

Palmitoyl Tripeptide-1 (Pal-GHK) is a lipopeptide that stimulates collagen production. It's one of two peptides in the Matrixyl 3000 complex, working synergistically with Palmitoyl Tetrapeptide-7.

Full details →

Side-by-Side Comparison

AspectFGLPalmitoyl Tripeptide-1
MechanismBinds to FGFR1 (fibroblast growth factor receptor 1) to activate downstream signaling cascades that promote neurite outgrowth, synaptic plasticity, and neuronal survival.Mimics the skin's own mechanism for producing collagen by acting as a messenger peptide that signals fibroblasts to produce more collagen and other extracellular matrix components.
Typical DosageResearch protocols have used subcutaneous doses ranging from 1-10mg. Intranasal administration also studied. Optimal dosing not established.Topical: Typically 2-4% in serums, often combined with Palmitoyl Tetrapeptide-7 as Matrixyl 3000.
AdministrationSubcutaneous injection or intranasal administration. Research compound with limited human dosing data.Topical application 1-2 times daily. The palmitoyl group enhances skin penetration compared to non-lipidated versions.
Side EffectsLimited human data available. Animal studies show good tolerability.Very well-tolerated. Suitable for most skin types including sensitive skin.
Best For

Key Differences

Unique to FGL:

Unique to Palmitoyl Tripeptide-1:

Detailed Analysis

FGL and Palmitoyl Tripeptide-1 are used for different purposes and have limited overlap in their applications.

Which Should You Choose?

Choose FGL for Cognitive Performance. Choose Palmitoyl Tripeptide-1 for Anti-Aging & Longevity, Skin Health & Aesthetics.

Ready to Learn More?